These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10885356)

  • 21. Randomized, Double-Blind, Placebo-Controlled Studies to Assess Safety and Prophylactic Efficacy of Naphthoquine-Azithromycin Combination for Malaria Prophylaxis in Southeast Asia.
    Yang H; Wang J; Liu H; Li X; Nie R; Li C; Wang H; Wang Q; Cao Y; Cui L
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand.
    Walsh DS; Looareesuwan S; Wilairatana P; Heppner DG; Tang DB; Brewer TG; Chokejindachai W; Viriyavejakul P; Kyle DE; Milhous WK; Schuster BG; Horton J; Braitman DJ; Brueckner RP
    J Infect Dis; 1999 Oct; 180(4):1282-7. PubMed ID: 10479159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single dose tafenoquine for preventing relapse in people with plasmodium vivax malaria-an updated meta-analysis.
    Anjum MU; Naveed AK; Mahmood SN; Naveed OK
    Travel Med Infect Dis; 2020; 36():101576. PubMed ID: 32036012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of radical treatment with halofantrine on the prevention of imported Plasmodium falciparum malaria].
    Baudon D; Bernard J; Mouliat-Pelat JP; Martet G; Sarrouy J; Touzé JE; Spiegel A; Lantrade P; Picq JJ
    Ann Soc Belg Med Trop; 1992 Dec; 72(4):263-70. PubMed ID: 1292422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area.
    Dow GS; McCarthy WF; Reid M; Smith B; Tang D; Shanks GD
    Malar J; 2014 Feb; 13():49. PubMed ID: 24502679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tafenoquine for malaria prophylaxis in adults: An integrated safety analysis.
    Novitt-Moreno A; Ransom J; Dow G; Smith B; Read LT; Toovey S
    Travel Med Infect Dis; 2017; 17():19-27. PubMed ID: 28495354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy, safety and acceptability of halofantrine in the treatment of acute Plasmodium falciparum malaria in African children (Gabon).
    Richard-Lenoble D; Kombila M; Martz M; Gendrel D; Gendrel C; Moreno JL; Engohan E; Blanc G; Dupasquier I; Iannascoli F
    J Trop Pediatr; 1992 Feb; 38(1):7-11. PubMed ID: 1573696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tafenoquine: the new kid on the block.
    Chen V; Daily JP
    Curr Opin Infect Dis; 2019 Oct; 32(5):407-412. PubMed ID: 31305490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro interaction of tafenoquine and chloroquine in Plasmodium falciparum from northwestern Thailand.
    Vollnberg A; Prajakwong S; Sirichaisinthop J; Wiedermann G; Wernsdorfer G; Wernsdorfer WH
    Wien Klin Wochenschr; 2003; 115 Suppl 3():28-32. PubMed ID: 15508777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The halofantrine treatment of Plasmodium falciparum malaria. Clinical experience].
    Villota Arrieta J; Barreiro Casal G; García López M; Cilleruelo Ortega MJ; Mellado Peña MJ; Pérez Jurado ML; Martín Fontelos P
    An Esp Pediatr; 1996 Feb; 44(2):117-20. PubMed ID: 8830568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trial of halofantrine with modified doses for treatment of malaria in the hospital for tropical diseases.
    Krudsood S; Singhasivanon P; Silachamroon U; Treeprasertsuk S; Kaivipakbanyai W; Chalermrut K; Phophak N; Horton J; Kyle D; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2001 Jun; 32(2):255-61. PubMed ID: 11556573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of tafenoquine for malaria chemoprophylaxis (1998-2020): A systematic review and meta-analysis.
    Maier JD; Siegfried S; Gültekin N; Stanga Z; Baird JK; Grobusch MP; Schlagenhauf P
    Travel Med Infect Dis; 2021; 39():101908. PubMed ID: 33227500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial.
    Vélez ID; Hien TT; Green JA; Martin A; Sharma H; Rousell VM; Breton JJ; Ernest TB; Rolfe K; Taylor M; Mohamed K; Jones SW; Chau NH; Hoa NT; Duparc S; Tan LK; Goyal N
    Lancet Child Adolesc Health; 2022 Feb; 6(2):86-95. PubMed ID: 34871570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical trial with halofantrine on patients with falciparum malaria in Colombia.
    Restrepo M; Botero D; Marquez RE; Boudreau EF; Navaratnam V
    Bull World Health Organ; 1996; 74(6):591-7. PubMed ID: 9060219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecule of the month. Tafenoquine succinate.
    Drug News Perspect; 2003 May; 16(4):238. PubMed ID: 12942153
    [No Abstract]   [Full Text] [Related]  

  • 37. Tafenoquine: a toxicity overview.
    Chu CS; Hwang J
    Expert Opin Drug Saf; 2021 Mar; 20(3):349-362. PubMed ID: 33306921
    [No Abstract]   [Full Text] [Related]  

  • 38. Gender differences in gastrointestinal disturbances and plasma concentrations of tafenoquine in healthy volunteers after tafenoquine administration for post-exposure vivax malaria prophylaxis.
    Edstein MD; Nasveld PE; Kocisko DA; Kitchener SJ; Gatton ML; Rieckmann KH
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):226-30. PubMed ID: 16814823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primaquine for prevention of malaria in travelers.
    Baird JK; Fryauff DJ; Hoffman SL
    Clin Infect Dis; 2003 Dec; 37(12):1659-67. PubMed ID: 14689349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
    Grobusch MP; Lell B; Schwarz NG; Gabor J; Dornemann J; Potschke M; Oyakhirome S; Kiessling GC; Necek M; Langin MU; Klein Klouwenberg P; Klopfer A; Naumann B; Altun H; Agnandji ST; Goesch J; Decker M; Salazar CL; Supan C; Kombila DU; Borchert L; Koster KB; Pongratz P; Adegnika AA; Glasenapp Iv; Issifou S; Kremsner PG
    J Infect Dis; 2007 Dec; 196(11):1595-602. PubMed ID: 18008242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.